Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

REACH

Aluminium potassium bis(sulphate)

EC number: 233-141-3 | CAS number: 10043-67-1

Life Cycle description
Uses advised against

Toxicological information

Endpoint summary

Administrative data

Description of key information

Based on the long-term key study from Oneda et al. the calculated LD50-mouse oral should be >  2000 mg/kg bw.
This result was used for classification of  the substance. 
Based on the oral NOAEL value of the key study the inhalative NOAEL  of the substance was calculated.
NOAEL inhalative calculated from NOAEL oral:
NOAEL inhalative = 13.05 mg/m³. 
The calculated LC50-inhalative should be > 5 mg/L (Limit CLP).
Based on the key study ( ATSDR report and publication of Lansdown) the calculated LD50-dermal 
of aluminium potassium bis sulphate from read across substance aluminium sulfate resulted in a 
calculated LD50-dermal of 100000 mg/kg bw aluminium potassium bis sulphate.
Based on all acute toxicity results aluminium potassium bis sulphate is not classified as acute toxic oral, inhalative and dermal according 
EU regulation 1272/2008 and EU regulation 286/2011 (2. ATP).

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Reference

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

1994

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: well documented study from Oneda et al according to EU Method B.33 (Combined Chronic Toxicity / Carcinogenicity Test),peer-reviewed report from ATSDR (2008)

Qualifier:

equivalent or similar to guideline

Guideline:

other: EU Method B.33 (Combined Chronic Toxicity / Carcinogenicity Test)

Deviations:

not specified

Principles of method if other than guideline:

In a preliminary study with male and female mice B6C3F1 5 week-diet was given in concentration of 2, 1, 0.2 and 0% Aluminium potassium bis(sulphate) for testing maximal dose of the substance.

GLP compliance:

not specified

Test type:

other: combined repeated dose and carcinogenicity

Limit test:

Species:

mouse

Strain:

B6C3F1

Sex:

male/female

Route of administration:

oral: feed

Vehicle:

other: basal diet

Doses:

Preliminary study: 5 weeks, daily dietConcentration: 2, 1, 0.2 and 0% (w/w)No deaths, no abnormalities in clinical signs, food consumption, body weight or pathological evaluations at any dose.Main study: 20 months, daily dietConcentrations: 10, 5, 2.5, 1 and 0 % (w/w)

No. of animals per sex per dose:

300 male, 300 female

Control animals:

yes

Preliminary study:

2, 1, 0.2 and 0% (w/w) AlK(SO4)2*12H2O = 3000, 1500, 300 and 0 mg aluminium potassium bis(sulphate) or 170, 85, 17 and 0 mg Al/kg bw

Sex:

male/female

Dose descriptor:

LD0

Effect level:

2 other: %

Based on:

test mat.

Remarks:

Aluminium potassium bis(sulphate)*12H2O

Sex:

male/female

Dose descriptor:

LD0

Effect level:

3 000 mg/kg bw

Based on:

test mat.

Remarks:

AlK(SO4)2*12H2O

Sex:

male/female

Dose descriptor:

LD0

Effect level:

170 mg/kg bw

Based on:

dissolved

Remarks:

Aluminium from AlK(SO4)2*12H2O

Sex:

male/female

Dose descriptor:

other: NOAEL

Effect level:

8 160 other: mg/kg bw/day

Based on:

other: calculated from 10 % Aluminium potassium bis sulphate in diet

Sex:

male/female

Dose descriptor:

LD50

Effect level:

> 2 000 mg/kg bw

Based on:

other: calculated from oral NOAEL: based on relation LD50/NOAEL ca. 2.3

Remarks on result:

other: Calculation LD50 from oral NOAEL= 8160 mg/kg bw/day: according to ATSDR 2008 p. 51-61 relation LD50 oral/NOAEL oral ca. 2.26. Therefore based on NOAEL oral from study of Oneda et al. the calculated LD50 oral is LD50 = 8160x2.26 = 18442 mg/kg bw

Mortality:

No death

Clinical signs:

other: No abnormalities in clinical signs, food consumption, body weight or pathological evaluations.

Interpretation of results:

not classified

Remarks:

Migrated informationCriteria used for interpretation of results: EU

Conclusions:

LD0-5 weeks male/female Mice B6C3F1 = 2 % (w/w) as Aluminium potassium bis sulphate dodecahydrate in diet.LD0-5 weeks male/female mouse B6C3F1 = 3000 mg/kg bw Aluminium potassium bis sulphate dodecahydrate = LD0-5 weeks male/female mouse B6C3F1 = 1634 mg/kg bw Aluminium potassium bis sulphateCalculation of LD50 from NOAEL oral :Relation LD50 oral/NOAEL oral according to ATSDR 2008 ca. 2.26NOAEL oral - 20 months mouse B6C3F1 = 8160 mg/kg bw/day (see Key study Repeated dose toxicity oral)Calculated LD50 oral from NOAEL oral = 8160 x 2.26 = 18144 mg/kg bw Aluminium potassium bis sulphate.The calculated LD50 value should be LD50 > 2000 mg/kg bw (Limit acute oral toxicity GHS).Therefore the substance Aluminium potassium bis sulphate is not classified as acute oral toxic according to EU regulation 1272/2008 and EU regulation 286/2011 (2. ATP) under the test conditions.

Executive summary:

LD0-5 weeks male/female Mice B6C3F1 = 2 % (w/w) as Aluminium potassium bis sulphate dodecahydrate.

LD0-5 weeks male/female mouse B6C3F1 = 3000 mg/kg bw Aluminium potassium bis sulphate dodecahydrate =

LD0-5 weeks male/female mouse B6C3F1 = 1634 mg/kg bw Aluminium potassium bis sulphate.

Calculation of LD50 from NOAEL oral :

Relation LD50 oral/NOAEL oral according to ATSDR 2008 ca. 2.26

NOAEL oral - 20 months mouse B6C3F1 = 8160 mg/kg bw/day (see Key study Repeated dose toxicity oral).

Calculated LD50 oral from NOAEL oral = 8160 x 2.26 = 18144 mg/kg bw Aluminium potassium bis sulphate.

The calculated LD50 value should be LD50 > 2000 mg/kg bw (Limit acute oral toxicity GHS).

Therefore the substance Aluminium potassium bis sulphate is not classified as acute oral toxic according to EU regulation 1272/2008 and EU regulation 286/2011 (2. ATP) under the test conditions.

Endpoint conclusion

Endpoint conclusion:: no adverse effect observed
Dose descriptor:: LD50
Value:: 8 160 mg/kg bw
Quality of whole database:: Based on the long-term key study from Oneda et al. the calculated LD50 oral from NOAEL oral= 8160 mg/kg bw/day should be > 2000 mg/kg bw Aluminium potassium bis sulphate.

Acute toxicity: via inhalation route

Link to relevant study records

Reference

Endpoint:

acute toxicity: inhalation

Type of information:

calculation (if not (Q)SAR)

Remarks:

Migrated phrase: estimated by calculation

Adequacy of study:

key study

Study period:

2012

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Calculated from long-term oral key study from Oneda et al.

Qualifier:

equivalent or similar to guideline

Guideline:

other:

Deviations:

not specified

Principles of method if other than guideline:

In the main study with male and female mice B6C3F1 5 week-diet was given in concentration of 10, 5, 2.5, 1 and 0 % (w/w) in diet.Exposure duration: 20 months, daily diet.Effects: No deaths, no abnormalities in clinical signs, food consumption, body weight or pathological evaluations at any dose.Calculation from repeated dose oral NOAEL-20 months for mouse = 8160 mg Aluminium potassium bis sulphate/kg bw*d.Oral absorption rate: 1%Inter-species factor: 1/7x2.5Intra-species factor: 1/5 for workersInhalative absorption rate: 50%Worker body weight: 70 kgInhalation volumen/8h: 10 m³ airCalculation NOAEL-inhalative mouse: 8160/100/7x2.5/5x2x70/10 = 13.05 mg Aluminium potassium bis sulphate/m³ air.

GLP compliance:

not specified

Test type:

fixed concentration procedure

Limit test:

yes

Species:

mouse

Strain:

B6C3F1

Sex:

male/female

Route of administration:

other: calculation from oral NOAEL

Type of inhalation exposure:

other: calculation from oral NOAEL

Vehicle:

other: calculation from oral NOAEL

Details on inhalation exposure:

Calculation from oral NOAEL

Analytical verification of test atmosphere concentrations:

Remarks:

calculation from oral NOAEL

Duration of exposure:

600 d

Concentrations:

Administration of aluminium potassium sulphate (APS) to B6C3F1 mice (60 males and 60 females per group) at levels of 0, 1,2.5, 5 or 10% in the diet for 20 months (equivalent to 1500, 3750, 7500 or 15000 mg/kgbw/day of aluminium potassium sulphate and 85, 213, 427 or 853 mg Al/kg bw/day).

No. of animals per sex per dose:

300 male, 300 female

Control animals:

yes

Sex:

male/female

Dose descriptor:

other: NOAEL

Effect level:

13.05 mg/m³ air

Based on:

other: test material: Calculation from oral NOAEL-mouse

Exp. duration:

600 d

Remarks on result:

other: calculation from oral NOAEL-600d mouse

Mortality:

No death

Clinical signs:

other: No abnormalities in clinical signs, food consumption, body weight or pathological evaluations

Body weight:

no effects

Gross pathology:

no effects

Interpretation of results:

not classified

Remarks:

Migrated informationCriteria used for interpretation of results: EU

Conclusions:

Calculation based on long-term oral key study of aluminium potassium bis sulphate from Oneda et al. resulted in an NOAEL inhalative -20 month mouse of NOAEL inhalative= 13.05 mg Aluminium potassium bis sulphate/m³ air.The resulting LC50 inhalative should be > 5 mg/L air (Limit GHS).Therefore the substance is not classified according to EU regulation 1272/2008 and EU regulation286/2011 (2. ATP).

Executive summary:

Calculation based on long-term oral key study of aluminium potassium bis sulphate from Oneda et al.

resulted in an NOAEL inhalative -20 month mouse of NOAEL inhalative = 13.05 mg Aluminium potassium bis sulphate/m³ air.

The resulting LC50 inhalative should be > 5 mg/L air (Limit GHS).

Therefore the substance is not classified according to EU regulation 1272/2008 and EU regulation

286/2011 (2. ATP).

Endpoint conclusion

Endpoint conclusion:: no adverse effect observed
Dose descriptor:: LC50
Value:: 13.05 mg/m³ air
Quality of whole database:: Calculated from oral NOAEL-20 month mouse = 8160 mg/kg bw*d the LC50 inhalative should be > 5 mg/m³ Aluminium potassium bis sulphate.

Acute toxicity: via dermal route

Link to relevant study records

Reference

Endpoint:

acute toxicity: dermal

Type of information:

migrated information: read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: peer-reviewed report

Qualifier:

equivalent or similar to guideline

Guideline:

EPA OPP 81-2 (Acute Dermal Toxicity)

Deviations:

not specified

GLP compliance:

not specified

Test type:

standard acute method

Species:

mouse

Strain:

other: Carworth TF1

Sex:

female

Type of coverage:

not specified

Vehicle:

not specified

Duration of exposure:

5d/ 1x/d

Control animals:

not specified

Sex:

female

Dose descriptor:

LD0

Effect level:

10 other: % (w/v)

Based on:

dissolved

Remarks:

Aluminium as Aluminium sulfate

Remarks on result:

other: LD0 = 10% (w/v) Aluminium as Aluminium sulfate

Mortality:

no mortality

Clinical signs:

other: no skin damage

Interpretation of results:

not classified

Remarks:

Migrated informationCriteria used for interpretation of results: EU

Conclusions:

NOAEL-5d/1x/d mouse TFI: 10% (w/v) = 100 g/L as Aluminium sulfateCalculated for KAl(SO4)2: NOAEL: 13.25 % (w/v) = 132.5 g/L as KAl(SO4)2.The estimated LD50 should be > 2000 mg/kg bw for Aluminium potassium bis sulphate.Therefore aluminium potassium bis sulphate is not classified according to EU Regulation 1272/2008and 286/2011 (2. ATP).

Executive summary:

NOAEL-5d/1x/d mouse TFI: 10% (w/v) = 100 g/L as Aluminium sulfate

Calculated for KAl(SO4)2:

NOAEL: 13.25 % (w/v) = 132.5 g/L as KAl(SO4)2.

The estimated LD50 should be > 2000 mg/kg bw for Aluminium potassium bis sulphate.

Therefore aluminium potassium bis sulphate is not classified according to EU Regulation 1272/2008

and 286/2011 (2. ATP).

Endpoint conclusion

Endpoint conclusion:: no adverse effect observed
Dose descriptor:: LD50
Value:: 100 000 mg/kg bw
Quality of whole database:: Based on the key study the LD50 dermal is > 2000 mg/kg bw (Limit value GHS).

Additional information

Based on the long-term key study from Oneda et al. the calculated LD50-mouse oral should be > 2000 mg/kg bw.

This result was used for classification of the substance.

Based on the oral NOAEL of the key study the inhalative NOAEL of the substance was calculated.

Calculated NOAEL-inhalative: 13.05 mg/m³.

The corresponding LC50 -inhalative should be LC50 inhalative > 5 mg/L air (Limit CLP).

Based on the key study ( ATSDR report and publication of Lansdown) the calculated LD50-dermal

of aluminium potassium bis sulphate from read across substance aluminium sulfate resulted in an

calculated LD50-dermal of 100000 mg/kg bw aluminium potassium bis sulphate.

Based on all acute toxicity results aluminium potassium bis sulphate is not classified as acute oral, inhalative and dermal toxic

according EU regulation 1272/2008 and EU regulation 286/2011 (2. ATP).

Justification for selection of acute toxicity – oral endpoint
Well documented repeated dose study of aluminium potassium bis sulphate and peer-reviewed ATSDR
report. Calculation of LD50 oral from NOAEL oral.

Justification for selection of acute toxicity – inhalation endpoint
In the main study with male and female mice B6C3F1 5 week-diet was given in concentrations of 10, 5, 2.5, 1 and 0 % (w/w) in diet.
Exposure duration: 20 months, daily.
Effects: No deaths, no abnormalities in clinical signs, food consumption, body weight or pathological evaluations at any dose.
Calculation from repeated dose oral NOAEL-20 months for mouse = 8160 mg Aluminium potassium bis sulphate/kg bw/d.
Oral absorption rate: 1%
Inter-species factor: 1/7x2.5
Intra-species factor: 1/5 for workers
Inhalative absorption rate: 50%
Worker body weight: 70 kg
Inhalation volumen/8h: 10 m³ air
Calculation NOAEL-inhalative mouse: 8160/100/7x2.5/5x2x70/10 = 13.05 mg Aluminium potassium bis sulphate/m³ air.

Justification for selection of acute toxicity – dermal endpoint
Based on Key study the LD50 dermal is > 13.25% (m/v).
Calculated LD50: 100000 mg/kg bw

Justification for classification or non-classification

Based on the results of acute oral values and calculated long-term inhalative and acute dermal values

the substance aluminium potassium bis(sulphate) is not classified as acute oral, inhalative and dermal toxic

according CLP regulation EU 1272/2008 and EU regulation 286/2011 (2. ATP).

Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.